QPPV.COM KNOWLEDGE ASSESSMENT

The IME List in Pharmacovigilance: Important Medical Events, Seriousness and Practical Use

Test your understanding of the concepts covered by The IME List in Pharmacovigilance: Important Medical Events, Seriousness and Practical Use.

Question 1 of 10Pass mark: 80%

Question 1 of 10 An analyst observes a cluster of reports with IME-listed terms for one medicinal product. What is the most appropriate interpretation?

The cluster proves that the product caused the reported events The cluster establishes that the events are unexpected The cluster can justify focused review, but it does not by itself establish causality or signal validity The cluster means every report should be classified as serious without case review

Question 2 of 10 A case contains an event that is not on the IME list and has no explicit serious outcome. What can safely be concluded from the absence of an IME match?

The event is non-serious The event is unrelated to the medicinal product The event requires ordinary assessment; absence from the list does not establish non-seriousness The event is expected

Question 3 of 10 A company updates its MedDRA version but continues using an older IME configuration without assessing the impact. What is the main risk?

IME matching may become inconsistent with the terminology version and intended configuration All historical cases will automatically become non-serious Causality assessments will be invalidated by definition Expectedness will be determined incorrectly for every reaction

Question 4 of 10 A reaction is both serious and reported after exposure to a medicinal product, but the available information does not establish whether the product caused it. What does the IME list contribute to the causality assessment?

It establishes causality when the reaction PT is listed It rules out causality when the reaction PT is not listed It does not resolve causality, which must be assessed separately from seriousness It establishes causality only when the case is also unexpected

Question 5 of 10 Which statement best describes the relationship between the IME list and the formal seriousness framework?

The IME list is a separate legal definition that supersedes ICH E2A The IME list supports recognition and assessment of potentially important events but does not replace formal criteria or case-specific judgement The IME list determines seriousness only when a reaction has no coded MedDRA PT The IME list applies only to aggregate analysis and should not be used in ICSR processing

Question 6 of 10 A patient develops a clinically modest reaction, but a clinician intervenes to prevent a potentially life-threatening consequence. Which interpretation is most consistent with the seriousness framework?

The event cannot be serious because it was not described as severe The event may qualify as serious as an important medical event because intervention was needed to prevent a serious outcome The event is serious only if the intervention resulted in hospitalisation The event is non-serious unless its PT is included in the IME list

Question 7 of 10 A team uses IME-listed PTs to generate a dashboard of medically consequential events. Which conclusion is justified by such a dashboard alone?

The flagged events are a useful group for review, but the dashboard alone does not establish a product-related signal The product caused every event shown Every event shown is unexpected Every case shown meets an explicit seriousness outcome

Question 8 of 10 A patient experiences an event coded to a PT that is not on the IME list, but the event requires inpatient hospitalisation. How should seriousness be assessed?

The event is non-serious because it is not an IME-listed PT The event may be serious because hospitalisation is an explicit seriousness criterion, regardless of IME-list membership The event is serious only if the reporter also describes it as severe The event should be assessed as serious only if a causal relationship is established

Question 9 of 10 A case contains three reactions: one associated with hospitalisation, one with an IME-listed PT but no clear outcome, and one mild symptom. What is the best review approach?

Assign the same seriousness classification to all reactions because they belong to one case Assess each reaction on its own reported facts, while considering case-level handling separately Assess only the reaction that caused hospitalisation Treat every reaction as serious because one reaction meets a serious criterion

Question 10 of 10 A reporter describes an adverse reaction as severe, but it caused no death, life-threatening condition, hospitalisation, disability, congenital anomaly, or other medically important circumstance. What principle should guide the seriousness assessment?

Severity and seriousness are interchangeable, so the reaction is automatically serious Severity describes intensity, while seriousness is classified using regulatory outcomes and medically important circumstances A severe reaction is serious only when its PT appears on the IME list Severity is relevant only to causality assessment, not to clinical description

QPPV.com

The IME List in Pharmacovigilance: Important Medical Events, Seriousness and Practical Use

Cookie Settings